Enterococcus faecium DSM 2146 is a microaerophile, Gram-positive, coccus-shaped bacterium that was isolated from cheese.
Gram-positive coccus-shaped microaerophile Bacteria
SI-ID 8777
| @ref 20215 |
|
Last LPSN update
2026-02-09 11:18:56 |
| Domain Bacteria |
| Phylum Bacillota |
| Class Bacilli |
| Order Lactobacillales |
| Family Enterococcaceae |
| Genus Enterococcus |
| Species Enterococcus faecium |
| Full scientific name Enterococcus faecium (Orla-Jensen 1919) Schleifer and Kilpper-Bälz 1984 |
| Synonyms (1) |
| @ref | Name | Growth | Medium link | Composition | |
|---|---|---|---|---|---|
| 977 | COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) | Medium recipe at MediaDive  | Name: COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) Composition: Defibrinated sheep blood 50.0 g/l Columbia agar base | ||
| 977 | TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92) | Medium recipe at MediaDive | Name: TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92) Composition: Trypticase soy broth 30.0 g/l Agar 15.0 g/l Yeast extract 3.0 g/l Distilled water | ||
| 41995 | MEDIUM 29- Brain heart agar | Distilled water make up to (1000.000 ml);Brain heart infusion agar (52.000 g) | |||
| 119264 | CIP Medium 72 | Medium recipe at CIP | |||
| 119264 | CIP Medium 111 | Medium recipe at CIP | |||
| 119264 | CIP Medium 29 | Medium recipe at CIP |
| Test 1 | Test 2 | Test 3 | Test 4 | Test 5 | Test 6 | Test 7 | Test 8 | Test 9 | Test 10 | Test 11 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| @ref | 977 | 977 | 977 | 977 | 977 | 977 | 977 | 977 | 977 | 977 | 977 |
| Medium | Mueller-Hinton Agar | Mueller-Hinton Agar | Mueller-Hinton Agar | Mueller-Hinton Agar | Mueller-Hinton Agar | Mueller-Hinton Agar | Mueller Hinton | M 693 | M 693 | M 693 | M 693 |
| Manual annotation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Inhibition zone diameter in mm | Inhibition zone diameter in mm | Inhibition zone diameter in mm | Inhibition zone diameter in mm | Inhibition zone diameter in mm | Inhibition zone diameter in mm | Inhibition zone diameter in mm | Inhibition zone diameter in mm | Inhibition zone diameter in mm | Inhibition zone diameter in mm | Inhibition zone diameter in mm | |
| Amikacin 30µg (disc) | 14 | 14 | 14 | 16-18 | 16 | 14 | 14 | 8 | 8 | 8 | 10 |
| Ampicillin 10µg (disc) | 30-32 | 34 | 32 | 32 | 32 | 32 | 30 | 30 | 24 | 24 | 28 |
| Aztreonam 30µg (disc) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bacitracin 10Unit | 12 | 16 | 16 | 16 | 14 | 16-18 | 12 | 10 | n.d. | n.d. | n.d. |
| Cefalotin 30µg (disc) | 24-26 | 28 | 26 | 26-28 | 26 | 28 | 24 | 22 | n.d. | n.d. | n.d. |
| Cefazolin 30µg (disc) | 24 | 26-28 | 26 | 18 | 20-22 | 22-24 | 22 | 20 | n.d. | n.d. | n.d. |
| Cefiderocol 30µg (disc) | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | 0 | 0 | 10 |
| Cefotaxime 30µg (disc) | 26-28 | 28 | 28 | 28 | 26-28 | 30 | 24-26 | 22 | 18 | 18 | 24 |
| Ceftazidime 10µg (disc) | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | 0 | 0 | 10-12 |
| Ceftriaxone 30µg (disc) | 24-26 | 26 | 26 | 26-28 | 26-28 | 28 | 24-26 | 20-22 | 20 | 20 | 22 |
| Chloramphenicol 30µg (disc) | 26 | 26-28 | 26-28 | 28 | 26 | 28-30 | 26 | 22 | 20 | 20 | 20 |
| Ciprofloxacin 5µg (disc) | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | 12 | 12 | 16 |
| Clindamycin 10µg (disc) | 30 | 30 | 32 | 32 | 32 | 30 | 28 | 26-28 | 22 | 22 | 28 |
| Colistin 10µg (disc) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | n.d. | n.d. | n.d. |
| Colistin sulphate 10µg (disc) | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | 0 | 0 | 0 |
| Doxycycline 30µg (disc) | 30-32 | 30 | 30 | 32 | 28-30 | 32 | 30 | 24-26 | n.d. | n.d. | n.d. |
| Erythromycin 15µg (disc) | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 16 | 14-16 | 14-16 | 16 |
| Fosfomycin 50µg (disc) | 20 | 22 | 20 | 20 | 24 | 22 | 16-18 | 18 | 16 | 16 | 16 |
| Gentamicin 30µg (disc) | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | 12 | 12 | 10 |
| Gentamycin 10µg (disc) | n.d. | n.d. | n.d. | ||||||||
| Imipenem 10µg (disc) | 30 | 32 | 32 | 32 | 30-32 | 32-34 | 30 | 28 | 22 | 22 | 28 |
| Kanamycin 30µg (disc) | 10 | 10 | 12 | 12 | 24 | 24 | 12 | 6 | 6 | 6 | 8 |
| Levofloxacin 5µg (disc) | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | 12 | 12 | 16 |
| Lincomycin 15µg (disc) | 24 | 24-26 | 26 | 26 | 26 | 26 | 24 | 22 | n.d. | n.d. | n.d. |
| Linezolid 10µg (disc) | 30 | 28 | 22-24 | 24-26 | 24 | 28 | 28-30 | 28 | 24 | 24 | 26 |
| Meropenem 10µg (disc) | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | 20 | 20 | 24 |
| Mezlocillin 30µg (disc) | 28 | 30 | 30 | 30 | 28 | 30 | 28 | 24-26 | n.d. | n.d. | n.d. |
| Moxifloxacin 5µg (disc) | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 16 | 12 | 12 | 16 |
| Neomycin 30µg (disc) | 14-16 | 14-16 | 14 | 16-18 | 16 | 14 | 14-16 | 8 | n.d. | n.d. | n.d. |
| Nitrofurantoin 100µg (disc) | 12 | 10 | 12-14 | 16-18 | 18 | 18 | 18 | 8 | 8 | 8 | 8 |
| Norfloxacin 10µg (disc) | 18 | 18-20 | 18 | 18 | 20 | 20 | 18 | 12 | n.d. | n.d. | n.d. |
| Nystatin 100Unit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | n.d. | n.d. | n.d. |
| Ofloxacin 5µg (disc) | 16 | 16 | 16 | 16 | 18 | 18 | 16 | 12 | 12-14 | 12-14 | 12-14 |
| Oxacillin 5µg (disc) | 22 | 24 | 24 | 22-24 | 20 | 22 | 22 | 20 | 18 | 18 | 20 |
| Penicillin G 6µg (disc) | 30 | 32 | 30 | 30-32 | 28-30 | 30 | 30 | 28-30 | 24 | 24 | 28 |
| Pipemidic acid 20µg (disc) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | n.d. | n.d. | n.d. |
| Piperacillin/Tazobactam 40µg (disc) | 28 | 28 | 26 | 26-28 | 26 | 24-26 | 24-26 | 22 | n.d. | n.d. | n.d. |
| Piperacillin/Tazobactam 110µg (disc) | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | 24 | 24 | 22 |
| Polymyxin B 300Unit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Quinupristin/Dalfopristin 15µg (disc) | 24-26 | 24 | 24 | 24-26 | 24-26 | 26 | 24 | 20 | 18 | 18 | 20 |
| Rifampicin 5µg (disc) | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | 22 | 22 | 26 |
| Teicoplanin 30µg (disc) | 20 | 18 | 20 | 18-20 | 20 | 20 | 18 | 14-16 | 16-18 | 16-18 | 18 |
| Tetracycline 30µg (disc) | 30-32 | 32-34 | 32 | 30 | 32 | 34-36 | 26-28 | 24-26 | 22 | 22 | 20-22 |
| Ticarcillin 75µg (disc) | 30-32 | 34 | 30-32 | 32 | 30-32 | 32-34 | 30 | 28-30 | 24-26 | 24-26 | 30 |
| Tigecycline 15µg (disc) | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | 18 | 18 | 18-20 |
| Trimethoprim-sulfamethoxazole (1:19) 10µg (disc) | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | 0 | 0 | 0 |
| Vancomycin 30µg (disc) | 22 | 22 | 22 | 22 | 24 | 24 | 20-22 | 18 | 14 | 14 | 18-20 |
| @ref | Salt | Growth | Tested relation | Concentration | |
|---|---|---|---|---|---|
| 119264 | NaCl | positive | growth | 6.5 % |
| @ref | Murein short key | Type | |
|---|---|---|---|
| 977 | A11.31 | A4alpha L-Lys-D-Asp |
| @ref | Chebi-ID | Metabolite | Utilization activity | Kind of utilization tested | |
|---|---|---|---|---|---|
| 68381 | 29016 ChEBI | arginine | + | hydrolysis | from API rID32STR |
| 68381 | 18333 ChEBI | D-arabitol | - | builds acid from | from API rID32STR |
| 68381 | 16899 ChEBI | D-mannitol | + | builds acid from | from API rID32STR |
| 68381 | 16443 ChEBI | D-tagatose | - | builds acid from | from API rID32STR |
| 119264 | 4853 ChEBI | esculin | + | hydrolysis | |
| 68381 | 28087 ChEBI | glycogen | - | builds acid from | from API rID32STR |
| 119264 | 606565 ChEBI | hippurate | - | hydrolysis | |
| 68381 | 30849 ChEBI | L-arabinose | + | builds acid from | from API rID32STR |
| 68381 | 17716 ChEBI | lactose | + | builds acid from | from API rID32STR |
| 68381 | 17306 ChEBI | maltose | + | builds acid from | from API rID32STR |
| 68381 | 6731 ChEBI | melezitose | - | builds acid from | from API rID32STR |
| 68381 | 28053 ChEBI | melibiose | - | builds acid from | from API rID32STR |
| 119264 | 17632 ChEBI | nitrate | - | reduction | |
| 119264 | 16301 ChEBI | nitrite | - | reduction | |
| 68381 | 27941 ChEBI | pullulan | - | builds acid from | from API rID32STR |
| 68381 | 16634 ChEBI | raffinose | - | builds acid from | from API rID32STR |
| 68381 | 30911 ChEBI | sorbitol | - | builds acid from | from API rID32STR |
| 68381 | 17992 ChEBI | sucrose | - | builds acid from | from API rID32STR |
| 68381 | 27082 ChEBI | trehalose | + | builds acid from | from API rID32STR |
| 68381 | 16199 ChEBI | urea | - | hydrolysis | from API rID32STR |
| @ref | ChEBI | Metabolite | Is resistant | Resistance conc. | |
|---|---|---|---|---|---|
| 977 | 161680 | Aztreonam | 30 µg (disc) | from Antibiotic test | |
| 977 | 37943 | Colistin | 10 µg (disc) | from Antibiotic test | |
| 977 | 37943 | Colistin sulphate | 10 µg (disc) | from Antibiotic test | |
| 977 | 7660 | Nystatin | 100 Unit | from Antibiotic test | |
| 977 | 75250 | Pipemidic acid | 20 µg (disc) | from Antibiotic test | |
| 977 | 8309 | Polymyxin B | 300 Unit | from Antibiotic test | |
| 977 | Trimethoprim-sulfamethoxazole (1:19) | 10 µg (disc) | from Antibiotic test |
| @ref | Chebi-ID | Metabolite | Production | |
|---|---|---|---|---|
| 68381 | 15688 ChEBI | acetoin | from API rID32STR |
| @ref | Value | Activity | Ec | |
|---|---|---|---|---|
| 68382 | acid phosphatase | + | 3.1.3.2 | from API zym |
| 68381 | Alanyl-Phenylalanyl-Proline arylamidase | - | from API rID32STR | |
| 119264 | alcohol dehydrogenase | + | 1.1.1.1 | |
| 68382 | alkaline phosphatase | - | 3.1.3.1 | from API zym |
| 68381 | alkaline phosphatase | - | 3.1.3.1 | from API rID32STR |
| 68382 | alpha-chymotrypsin | - | 3.4.21.1 | from API zym |
| 68382 | alpha-fucosidase | - | 3.2.1.51 | from API zym |
| 68382 | alpha-galactosidase | - | 3.2.1.22 | from API zym |
| 68381 | alpha-galactosidase | - | 3.2.1.22 | from API rID32STR |
| 68382 | alpha-glucosidase | - | 3.2.1.20 | from API zym |
| 68382 | alpha-mannosidase | - | 3.2.1.24 | from API zym |
| 68381 | arginine dihydrolase | + | 3.5.3.6 | from API rID32STR |
| 68382 | beta-galactosidase | - | 3.2.1.23 | from API zym |
| 119264 | beta-galactosidase | - | 3.2.1.23 | |
| 68381 | beta-galactosidase | + | 3.2.1.23 | from API rID32STR |
| 68382 | beta-glucosidase | - | 3.2.1.21 | from API zym |
| 68381 | beta-glucosidase | + | 3.2.1.21 | from API rID32STR |
| 68382 | beta-glucuronidase | - | 3.2.1.31 | from API zym |
| 68381 | beta-glucuronidase | - | 3.2.1.31 | from API rID32STR |
| 977 | catalase | - | 1.11.1.6 | |
| 119264 | catalase | - | 1.11.1.6 | |
| 68382 | cystine arylamidase | - | 3.4.11.3 | from API zym |
| 977 | cytochrome-c oxidase | - | 1.9.3.1 | |
| 68382 | esterase (C 4) | + | from API zym | |
| 68382 | esterase lipase (C 8) | + | from API zym | |
| 119264 | gamma-glutamyltransferase | - | 2.3.2.2 | |
| 68382 | leucine arylamidase | + | 3.4.11.1 | from API zym |
| 68382 | lipase (C 14) | - | from API zym | |
| 119264 | lysine decarboxylase | - | 4.1.1.18 | |
| 68382 | N-acetyl-beta-glucosaminidase | - | 3.2.1.52 | from API zym |
| 68382 | naphthol-AS-BI-phosphohydrolase | + | from API zym | |
| 119264 | ornithine decarboxylase | - | 4.1.1.17 | |
| 119264 | oxidase | - | ||
| 68381 | pyrrolidonyl arylamidase | + | 3.4.19.3 | from API rID32STR |
| 68382 | trypsin | - | 3.4.21.4 | from API zym |
| 68381 | urease | - | 3.5.1.5 | from API rID32STR |
| 68382 | valine arylamidase | - | from API zym |
| @ref | ADH (Arg) | beta GLU | beta GAR | beta GUR | alpha GAL | PAL | RIB | MAN | SOR | LAC | TRE | RAF | SAC | LARA | DARL | Acid from alpha-cyclodextrinCDEX | Acetoin production (Voges Proskauer test)VP | Alanyl-Phenylalanyl-Proline arylamidaseAPPA | beta GAL | Pyrrolidonyl arylamidasePyrA | N-Acetyl-glucosaminidasebeta NAG | Glycyl-tryptophan arylamidaseGTA | HIP | GLYG | PUL | MAL | MEL | MLZ | Acidification of methyl beta-D-glucopyranosideMbeta DG | TAG | beta MAN | URE | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 977 | + | + | - | - | - | - | + | + | - | + | + | - | - | + | - | + | + | - | + | + | +/- | +/- | - | - | - | + | - | - | + | - | - | - | |
| 977 | + | + | - | - | - | - | + | + | - | + | + | - | - | + | - | + | + | - | + | + | + | + | - | - | - | + | - | - | + | - | + | - | |
| 977 | + | + | + | - | - | - | + | + | - | + | + | - | - | + | - | + | + | - | + | + | + | + | + | - | - | + | - | - | + | - | + | - | |
| 977 | + | + | - | - | - | - | +/- | + | - | + | + | - | - | + | - | + | + | - | + | + | + | + | + | - | - | + | - | - | +/- | - | + | - | |
| 977 | + | + | - | - | - | - | + | + | - | + | + | - | - | + | - | - | + | - | + | + | - | - | - | - | - | + | - | - | - | - | +/- | - | |
| 977 | + | + | - | - | - | - | + | + | - | + | + | - | - | + | - | - | + | - | + | + | - | + | + | - | - | + | - | - | +/- | - | - | - | |
| 977 | + | + | +/- | - | - | - | + | + | - | + | + | - | - | + | - | - | + | - | + | + | + | + | - | - | - | + | - | - | - | - | + | - | |
| 977 | + | + | +/- | - | - | - | + | + | - | + | + | - | - | + | - | +/- | + | - | + | + | + | + | - | - | - | + | - | - | - | - | + | - | |
| 977 | + | + | + | - | - | - | + | + | - | + | + | - | - | + | - | - | + | - | + | + | + | + | - | - | - | + | - | - | - | - | + | - | |
| 977 | + | + | - | - | - | - | + | + | - | + | + | - | - | + | - | + | + | - | + | + | - | - | - | - | - | + | - | - | +/- | - | - | - |
| Topic | Title | Authors | Journal | DOI | Year | |
|---|---|---|---|---|---|---|
| Hygiene Efficacy of Short Cycles in Domestic Dishwashers. | Kudla M, Tewes TJ, Gibbin-Lameira E, Harcq L, Bockmuhl DP. | Microorganisms | 10.3390/microorganisms13071542 | 2025 | | |
| Establishment of a Real-Time PCR Assay for the Detection of Devriesea agamarum in Lizards. | Brockmann M, Leineweber C, Hellebuyck T, Martel A, Pasmans F, Gentil M, Muller E, Marschang RE. | Animals (Basel) | 10.3390/ani13050881 | 2023 | | |
| Antimicrobials cetylpyridinium-chloride and miramistin demonstrate non-inferiority and no "protein-error" compared to established wound care antiseptics in vitro. | Rembe JD, Thompson VD, Stuermer EK. | AIMS Microbiol | 10.3934/microbiol.2022026 | 2022 | | |
| Bacteria Are New Targets for Inhibitors of Human Farnesyltransferase. | Weber L, Hagemann A, Kaltenhauser J, Besser M, Rockenfeller P, Ehrhardt A, Stuermer E, Bachmann HS. | Front Microbiol | 10.3389/fmicb.2021.628283 | 2021 | | |
| Systematic Investigation of Resistance Evolution to Common Antibiotics Reveals Conserved Collateral Responses across Common Human Pathogens. | Rodriguez de Evgrafov MC, Faza M, Asimakopoulos K, Sommer MOA. | Antimicrob Agents Chemother | 10.1128/aac.01273-20 | 2020 | | |
| Identification of RNase 8 as a novel human antimicrobial protein. | Rudolph B, Podschun R, Sahly H, Schubert S, Schroder JM, Harder J. | Antimicrob Agents Chemother | 10.1128/aac.00246-06 | 2006 | | |
| Enzymology | Colonization patterns of Enterococcus cecorum in two different broiler production cycles detected with a newly developed quantitative real-time PCR. | Jung A, Petersen H, Teske L, Rautenschlein S. | BMC Microbiol | 10.1186/s12866-017-1021-7 | 2017 | |
| Pathogenicity | Cationic Intrinsically Disordered Antimicrobial Peptides (CIDAMPs) Represent a New Paradigm of Innate Defense with a Potential for Novel Anti-Infectives. | Latendorf T, Gerstel U, Wu Z, Bartels J, Becker A, Tholey A, Schroder JM. | Sci Rep | 10.1038/s41598-019-39219-w | 2019 | |
| Enzymology | Development of a LightCycler PCR assay for detection and quantification of Aspergillus fumigatus DNA in clinical samples from neutropenic patients. | Spiess B, Buchheidt D, Baust C, Skladny H, Seifarth W, Zeilfelder U, Leib-Mosch C, Morz H, Hehlmann R. | J Clin Microbiol | 10.1128/jcm.41.5.1811-1818.2003 | 2003 | |
| Enzymology | Specific detection of Aspergillus species in blood and bronchoalveolar lavage samples of immunocompromised patients by two-step PCR. | Skladny H, Buchheidt D, Baust C, Krieg-Schneider F, Seifarth W, Leib-Mosch C, Hehlmann R. | J Clin Microbiol | 10.1128/jcm.37.12.3865-3871.1999 | 1999 | |
| Optimization, structural characterization, and biological applications of exopolysaccharide produced by Enterococcus faecium KT990028. | de Brito LP, da Silva EC, Lins LF, Severo de Medeiros R, Silva FCO, Pastrana L, Cavalcanti IDL, de Britto Lira-Nogueira MC, Cavalcanti MTH, Porto ALF. | Int J Biol Macromol | 10.1016/j.ijbiomac.2024.136926 | 2024 | | |
| Role of membrane vesicles in the transmission of vancomycin resistance in Enterococcus faecium. | Lehmkuhl J, Schneider JS, Werth KLV, Scherff N, Mellmann A, Kampmeier S. | Sci Rep | 10.1038/s41598-024-52310-1 | 2024 | | |
| Systematic screening of 42 vancomycin-resistant Enterococcus faecium strains for resistance, biofilm, and desiccation in simulated microgravity. | Arndt F, Siems K, Walker SV, Bryan NC, Leuko S, Moeller R, Boschert AL. | NPJ Microgravity | 10.1038/s41526-024-00447-8 | 2024 | | |
| In Vitro Evaluation of Halotolerant Bacillus velezensis 24.5 as a Promising Probiotic with Broad-Spectrum Antimicrobial Activity. | Diguta FC, Toma RC, Matei F. | Microorganisms | 10.3390/microorganisms13102240 | 2025 | | |
| Activity of antimicrobial examination gloves under realistic conditions: challenge not fulfilled. | Klupp EM, Knobling B, Franke G, Belmar Campos C, Maurer PM, Knobloch JK. | Antimicrob Resist Infect Control | 10.1186/s13756-023-01322-z | 2023 | | |
| New approaches to disinfection of thermolabile medical devices using an indirect method with cold atmospheric plasma-aerosol | Schaal T, Schmelz U, Pitten F, Tischendorf T. | Sci Rep | 2025 | | ||
| Breast milk preservation: thermal and non-thermal processes and their effect on microorganism inactivation and the content of bioactive and nutritional compounds. | Nunez-Delgado A, Mizrachi-Chavez VM, Welti-Chanes J, Macher-Quintana ST, Chuck-Hernandez C. | Front Nutr | 10.3389/fnut.2023.1325863 | 2023 | | |
| Domestic laundering of healthcare textiles: Disinfection efficacy and risks of antibiotic resistance transmission. | Cayrou C, Silver K, Owen L, Dunlop J, Laird K. | PLoS One | 10.1371/journal.pone.0321467 | 2025 | | |
| Techno-Functional Properties of Burgers Fortified by Wild Garlic Extract: A Reconsideration. | Kurcubic VS, Stajic SB, Miletic NM, Petkovic MM, Dmitric MP, Durovic VM, Heinz V, Tomasevic IB. | Foods | 10.3390/foods12112100 | 2023 | | |
| The Kinocidin Interleukin-26 Shows Immediate Antimicrobial Effects Even to Multi-resistant Isolates. | Hansen BT, Maschkowitz G, Podschun R, Fickenscher H. | Front Microbiol | 10.3389/fmicb.2021.757215 | 2021 | | |
| A Chimeric Cationic Peptide Composed of Human beta-Defensin 3 and Human beta-Defensin 4 Exhibits Improved Antibacterial Activity and Salt Resistance. | Yu W, Ning N, Xue Y, Huang Y, Guo F, Li T, Yang B, Luo D, Sun Y, Li Z, Wang J, He Z, Cheng S, Zhang X, Wang H. | Front Microbiol | 10.3389/fmicb.2021.663151 | 2021 | | |
| Dissolved Carbon Dioxide: The Lifespan of Staphylococcus aureus and Enterococcus faecalis in Bottled Carbonated Mineral Water. | Schalli M, Platzer S, Schmutz R, Ofner-Kopeinig P, Reinthaler FF, Haas D. | Biology (Basel) | 10.3390/biology12030432 | 2023 | | |
| Treatment of Clinically Important Bacteria With Cold Atmospheric Plasma. | Ding R, Song J, Huang X, Tan L, Rao X, Yang Y. | Microb Biotechnol | 10.1111/1751-7915.70219 | 2025 | | |
| Genus Veronica-Antioxidant, Cytotoxic and Antibacterial Activity of Phenolic Compounds from Wild and Cultivated Species. | Vrca I, Mikrut A, Fredotovic Z, Akrap K, Kremer D, Orhanovic S, Bacic K, Dunkic V, Nazlic M. | Antioxidants (Basel) | 10.3390/antiox14111308 | 2025 | | |
| Quantitative Insights and Visualization of Antimicrobial Tolerance in Mixed-Species Biofilms. | Dittmer M, Brill FHH, Kampe A, Geffken M, Rembe JD, Moll R, Alio I, Streit WR, Debus ES, Smeets R, Stuermer EK. | Biomedicines | 10.3390/biomedicines11102640 | 2023 | | |
| Pathogenicity | Influence of Proton Pump Inhibitors and Histamine Receptor 2 Antagonists on Blastocystis ST3 and Selected Microorganisms of Intestinal Microbiota In Vitro. | Lepczynska M, Dzika E, Chen W, Lu CY. | Clin Transl Gastroenterol | 10.14309/ctg.0000000000000325 | 2021 | |
| Resveratrol Reverts Tolerance and Restores Susceptibility to Chlorhexidine and Benzalkonium in Gram-Negative Bacteria, Gram-Positive Bacteria and Yeasts. | Migliaccio A, Stabile M, Bagattini M, Triassi M, Berisio R, De Gregorio E, Zarrilli R. | Antibiotics (Basel) | 10.3390/antibiotics11070961 | 2022 | | |
| Application of Digital Holographic Microscopy to Analyze Changes in T-Cell Morphology in Response to Bacterial Challenge. | Vom Werth KL, Kemper B, Kampmeier S, Mellmann A. | Cells | 10.3390/cells12050762 | 2023 | | |
| Novel Quinoline-Based Thiosemicarbazide Derivatives: Synthesis, DFT Calculations, and Investigation of Antitubercular, Antibacterial, and Antifungal Activities. | Ozcan E, Vagolu SK, Gunduz MG, Stevanovic M, Kokbudak Z, Tonjum T, Nikodinovic-Runic J, Cetinkaya Y, Dogan SD. | ACS Omega | 10.1021/acsomega.3c03018 | 2023 | | |
| Assessment of Microbial Reduction by Cage Washing and Thermal Disinfection using Quantitative Biologic Indicators for Spores, Viruses and Vegetative Bacteria. | Mocho JP, Coutot R, Douglas M, Szpiro L, Bouchami D, Durimel L, Moules V, Hardy P. | J Am Assoc Lab Anim Sci | 10.30802/aalas-jaalas-21-000026 | 2021 | | |
| Proteolytic Activities Expressed by Gastrointestinal Pathogens Bacillus cereus, Listeria monocytogenes and Enterococcus faecium in Different Growth Phases. | Abfalter CM, Schmidt TP, Wessler S. | Br Microbiol Res J | 10.9734/bmrj/2015/16402 | 2015 | | |
| N-terminus three residues deletion mutant of human beta-defensin 3 with remarkably enhanced salt-resistance. | Li T, Guo F, Wang Q, Fang H, Li Z, Wang D, Wang H. | PLoS One | 10.1371/journal.pone.0117913 | 2015 | | |
| "Life-like" assessment of antimicrobial surfaces by a new touch transfer assay displays strong superiority of a copper alloy compared to silver containing surfaces. | Knobloch JK, Tofern S, Kunz W, Schutze S, Riecke M, Solbach W, Wuske T. | PLoS One | 10.1371/journal.pone.0187442 | 2017 | | |
| Aromatic Herbs as a Source of Bioactive Compounds: An Overview of Their Antioxidant Capacity, Antimicrobial Activity, and Major Applications. | Grigore-Gurgu L, Dumitrascu L, Aprodu I. | Molecules | 10.3390/molecules30061304 | 2025 | | |
| The influence of probiotic bacteria and human gut microorganisms causing opportunistic infections on Blastocystis ST3. | Lepczynska M, Dzika E. | Gut Pathog | 10.1186/s13099-019-0287-8 | 2019 | | |
| Reliability of species detection in 16S microbiome analysis: Comparison of five widely used pipelines and recommendations for a more standardized approach. | Hiergeist A, Ruelle J, Emler S, Gessner A. | PLoS One | 10.1371/journal.pone.0280870 | 2023 | | |
| Exploiting thiol-functionalized benzosiloxaboroles for achieving diverse substitution patterns - synthesis, characterization and biological evaluation of promising antibacterial agents. | Nowicki K, Krajewska J, Stepniewski TM, Wielechowska M, Winska P, Kaczmarczyk A, Korpowska J, Selent J, Marek-Urban PH, Durka K, Wozniak K, Laudy AE, Lulinski S. | RSC Med Chem | 10.1039/d4md00061g | 2024 | | |
| Metabolism | RNase 7 contributes to the cutaneous defense against Enterococcus faecium. | Koten B, Simanski M, Glaser R, Podschun R, Schroder JM, Harder J. | PLoS One | 10.1371/journal.pone.0006424 | 2009 | |
| An evaluation of the retention of quality characteristics in fresh and freeze-dried alpine strawberries | Yurdugul S. | International journal of food science and technology. | 10.1111/j.1365-2621.2007.01533.x | 2008 | | |
| Lysozyme activates Enterococcus faecium to induce necrotic cell death in macrophages. | Grobner S, Fritz E, Schoch F, Schaller M, Berger AC, Bitzer M, Autenrieth IB. | Cell Mol Life Sci | 10.1007/s00018-010-0384-9 | 2010 | | |
| Comparison of regenerated and non-regenerated oxidized cellulose hemostatic agents. | Lewis KM, Spazierer D, Urban MD, Lin L, Redl H, Goppelt A. | Eur Surg | 10.1007/s10353-013-0222-z | 2013 | | |
| High hydrostatic pressure for disinfection of bone grafts and biomaterials: an experimental study. | Gollwitzer H, Mittelmeier W, Brendle M, Weber P, Miethke T, Hofmann GO, Gerdesmeyer L, Schauwecker J, Diehl P. | Open Orthop J | 10.2174/1874325000903010001 | 2009 | | |
| Photo-induced antibacterial activity of four graphene based nanomaterials on a wide range of bacteria. | Markovic ZM, Jovanovic SP, Maskovic PZ, Danko M, Micusik M, Pavlovic VB, Milivojevic DD, Kleinova A, Spitalsky Z, Todorovic Markovic BM. | RSC Adv | 10.1039/c8ra04664f | 2018 | | |
| Antimicrobial, Antivirulence, and Antiparasitic Potential of Capsicum chinense Jacq. Extracts and Their Isolated Compound Capsaicin. | Menezes RP, Bessa MAS, Siqueira CP, Teixeira SC, Ferro EAV, Martins MM, Cunha LCS, Martins CHG. | Antibiotics (Basel) | 10.3390/antibiotics11091154 | 2022 | | |
| Avian reovirus sigma C enhances the mucosal and systemic immune responses elicited by antigen-conjugated lactic acid bacteria. | Lin KH, Hsu AP, Shien JH, Chang TJ, Liao JW, Chen JR, Lin CF, Hsu WL. | Vaccine | 10.1016/j.vaccine.2012.04.043 | 2012 | | |
| Pathogenicity | Proposed phase 2/ step 2 in-vitro test on basis of EN 14561 for standardised testing of the wound antiseptics PVP-iodine, chlorhexidine digluconate, polihexanide and octenidine dihydrochloride. | Schedler K, Assadian O, Brautferger U, Muller G, Koburger T, Classen S, Kramer A. | BMC Infect Dis | 10.1186/s12879-017-2220-4 | 2017 | |
| Phylogeny | Molecular typing of Streptococcus suis strains isolated from diseased and healthy pigs between 1996-2016. | Prufer TL, Rohde J, Verspohl J, Rohde M, de Greeff A, Willenborg J, Valentin-Weigand P. | PLoS One | 10.1371/journal.pone.0210801 | 2019 | |
| [Claims of machine decontamination of dishes under hygienic conditions and of a small load in sewage--a contradiction?]. | Harpel S, Tilkes F, Kruger S. | Zentralbl Hyg Umweltmed | 1994 | | ||
| Pathogenicity | Survival of vancomycin-resistant and vancomycin-susceptible enterococci on dry surfaces. | Wendt C, Wiesenthal B, Dietz E, Ruden H. | J Clin Microbiol | 10.1128/jcm.36.12.3734-3736.1998 | 1998 | |
| Phylogeny | Helcococcus ovis, an emerging pathogen in bovine valvular endocarditis. | Kutzer P, Schulze C, Engelhardt A, Wieler LH, Nordhoff M. | J Clin Microbiol | 10.1128/jcm.00867-08 | 2008 | |
| Enzymology | Kinetics of Bacterial Inactivation by Peroxynitric Acid in the Presence of Organic Contaminants. | Yokoyama T, Miyazaki S, Akagi H, Ikawa S, Kitano K. | Appl Environ Microbiol | 10.1128/aem.01860-20 | 2021 | |
| Enzymology | Development of a rapid real-time PCR method as a tool to quantify viable Photobacterium phosphoreum bacteria in salmon (Salmo salar) steaks. | Mace S, Mamlouk K, Chipchakova S, Prevost H, Joffraud JJ, Dalgaard P, Pilet MF, Dousset X. | Appl Environ Microbiol | 10.1128/aem.03677-12 | 2013 | |
| Pathogenicity | Enterococcus hirae, Enterococcus faecium and Enterococcus faecalis show different sensitivities to typical biocidal agents used for disinfection. | Suchomel M, Lenhardt A, Kampf G, Grisold A | J Hosp Infect | 10.1016/j.jhin.2019.08.014 | 2019 | |
| Pathogenicity | Isopropanol at 60% and at 70% are effective against 'isopropanol-tolerant' Enterococcus faecium. | Gebel J, Gemein S, Kampf G, Pidot SJ, Buetti N, Exner M | J Hosp Infect | 10.1016/j.jhin.2019.01.024 | 2019 | |
| Requirements and infection prophylaxis for internally cooled implant drills. | Proff P, Bayerlein T, Kramer A, Allegrini S Jr, Dietze S, Fanghanel J, Gedrange T | Folia Morphol (Warsz) | 2006 | | ||
| Pathogenicity | Resistance of enterococci to heat and chemical agents. | Renner P, Peters J | Zentralbl Hyg Umweltmed | 1999 | | |
| Pathogenicity | [Inactivation of chlorhexidine for in vitro testing of disinfectants]. | Kampf G, Hofer M, Ruden H | Zentralbl Hyg Umweltmed | 1998 | | |
| Pathogenicity | Disinfection with gaseous formaldehyde. Third Part: Bactericidal and sporicidal effectiveness of gaseous formaldehyde and level of residues in dependence on concentration, temperature and relative humidity. | Casella ML, Schmidt-Lorenz W | Zentralbl Hyg Umweltmed | 1989 | | |
| Pathogenicity | Disinfection with gaseous formaldehyde. First Part: Bactericidal and sporicidal effectiveness of formaldehyde with and without formation of a condensing layer. | Casella ML, Schmidt-Lorenz W | Zentralbl Hyg Umweltmed | 1989 | | |
| Oxazoline scaffold in synthesis of benzosiloxaboroles and related ring-expanded heterocycles: diverse reactivity, structural peculiarities and antimicrobial activity. | Krajewska J, Nowicki K, Durka K, Marek-Urban PH, Winska P, Stepniewski T, Wozniak K, Laudy AE, Lulinski S | RSC Adv | 10.1039/d2ra03910a | 2022 | |
How to citeIf you want to cite this particular strain cite the following doi:
https://doi.org/10.13145/bacdive5295.20251217.10
When using BacDive for research please cite the following paper
BacDive in 2025: the core database for prokaryotic strain data
License